Coverage
-
March 15, 2011
Alnylam Pharmaceuticals Inc. and a German research organization on Tuesday settled their contract suit against a Massachusetts-based biomedical research group and a college trustee board over the prosecution of two families of RNA interference patent applications.
4 other articles on this case.
View all »